BridgeBio Pharma prices oversubscribed secondary share offering
BridgeBio Pharma (BBIO) announces pricing of an oversubscribed secondary offering aimed at diversifying its institutional shareholder base.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.